Abstract
Summary
We evaluated the associations of serum insulin-like growth factor-1 (IGF-1) with bone mineral density (BMD) and risk of fractures in Chinese patients with type 2 diabetes (T2D). We found positive associations between IGF-I and BMD and negative associations between IGF-I and all three modified 10-year probabilities of MOFs and HFs in men, but not in women.
Introduction
The objective was to investigate the associations of serum insulin-like growth factor-1 (IGF-1) with bone mineral density (BMD) and risk of fractures in Chinese patients with type 2 diabetes (T2D) in each gender.
Methods
This was a cross-sectional, retrospective study that included men over 50 years and postmenopausal women with T2D without medical conditions or medications known to significantly affect BMD or serum IGF-I levels. Data of IGF-1, bone metabolism markers, lumbar spine (LS), femoral neck (FN), and total hip (TH) BMD were obtained; 10-year probability of major osteoporotic fractures (MOFs) and hip fractures (HFs) was calculated and modified with rheumatoid arthritis, femoral neck T-score, and age. Correlations of IGF-1 levels with bone metabolism and risk of fractures were statistically analyzed in men and women, respectively.
Results
A total of 391 patients, including 226 men and 165 women, were included. The age, serum fasting C-peptide, glycosylated hemoglobin (HbA1c), bone formation marker, and all three modified 10-year probabilities of MOFs and HFs were higher in women than those in men (all p < 0.05). The levels of 25 hydroxyvitamin D (25OHD), IGF-1, and BMD were lower in women than those in men (all p < 0.05). In men, IGF-1 was positively correlated with FN and TH BMD (FN BMD: r = 0.267, p < 0.001; TH BMD: r = 0.235, p < 0.001) and negatively correlated with all three modified 10-year probabilities of MOFs (RA-modified MOFs: r = - 0.289, p < 0.001; age-modified MOFs: r = - 0.237, p < 0.001; FN T-score−modified MOFs: r = - 0.280, p < 0.001) and HFs (RA-modified HFs: r = - 0.291, p < 0.001; age-modified HFs: r = - 0.271, p < 0.001; FN T-score−modified HFs: r = - 0.270, p < 0.001), while no significant correlations were found between serum IGF-I and BMD and three modified 10-year probability in women.
Conclusions
According to this study, we found sex differences in the associations of serum IGF-1 with BMD and risk of fractures in Chinese patients with T2D. These results suggested that increasing serum IGF-1 might be a clinical target for protecting fractures in T2D, especially in men.
Similar content being viewed by others
References
Chiodini I, Catalano A, Gennari L, Gaudio A (2020) Osteoporosis and fragility fractures in type 2 diabetes. J Diabetes Res 2020:9342696. https://doi.org/10.1155/2020/9342696
Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, El-Hajj Fuleihan G, Josse R, Kendler DL, Kraenzlin M, Suzuki A, Pierroz DD, Schwartz AV, Leslie WD, Bone and Diabetes Working Group of IOF (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29:2585–2596. https://doi.org/10.1007/s00198-018-4650-2
Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM Study of Osteoporotic Fractures (SOF) Research Group; Osteoporotic Fractures in Men (MrOS) Research Group; Health, Aging, and Body Composition (Health ABC) Research Group(2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192. https://doi.org/10.1001/jama.2011.715
Schacter GI, Leslie WD (2017) DXA-based measurements in diabetes: can they predict fracture risk? Calcif Tissue Int 100:150–164. https://doi.org/10.1007/s00223-016-0191-x
Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD Registry. J Bone Miner Res 33:1923–1930. https://doi.org/10.1002/jbmr.3538
Geusens PP, Boonen S (2002) Osteoporosis and the growth hormone-insulin-like growth factor axis. Horm Res 58(Suppl 3):49–55. https://doi.org/10.1159/000066483
Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535–559. https://doi.org/10.1210/er.2007-0036
Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2007) Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 18:1675–1681. https://doi.org/10.1007/s00198-007-0430-0
Kanazawa I, Yamaguchi T, Sugimoto T (2011) Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 22:1191–1198. https://doi.org/10.1007/s00198-010-1310-6
Ardawi MS, Akhbar DH, Alshaikh A, Ahmed MM, Qari MH, Rouzi AA, Ali AY, Abdulrafee AA, Saeda MY (2013) Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone 56:355–362. https://doi.org/10.1016/j.bone.2013.06.029
Miyake H, Kanazawa I, Sugimoto T (2017) Decreased serum insulin-like growth factor-I is a risk factor for non-vertebral fractures in diabetic postmenopausal women. Intern Med 56:269–273. https://doi.org/10.2169/internalmedicine.56.7416
Kanazawa I, Notsu M, Miyake H, Tanaka K, Sugimoto T (2018) Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus. Osteoporos Int 29:2527–2535. https://doi.org/10.1007/s00198-018-4638-y
Dawson-Hughes B, Tosteson AN, Melton LJ 3rd, Baim S, Favus MJ, Khosla S, Lindsay RL, National Osteoporosis Foundation Guide Committee (2008) Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19:449–458. https://doi.org/10.1007/s00198-008-0559-5
Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505. https://doi.org/10.1093/aje/kwm106
Li M, Lv F, Zhang Z, Deng W, Li Y, Deng Z, Jiang Y, Wang O, Xing X, Xu L, Xia W (2016) Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density. Osteoporos Int 27:1907–1916. https://doi.org/10.1007/s00198-015-3475-5
Jiajue R, Qi X, Jiang Y, Wang Q, Wang W, Pei Y, Wang X, Huang W, Zheng X, Ning Z, Wang O, Li M, Xing X, Yu W, Xu L, Xia W (2019) Incident fracture risk in type 2 diabetic postmenopausal women in Mainland China: Peking Vertebral Fracture Study. Calcif Tissue Int 105:466–475. https://doi.org/10.1007/s00223-019-00598-x
Liu S, Chen R, Ding N, Wang Q, Huang M, Liu H, Xie Z, Ou Y, Sheng Z (2020) Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women. J Endocrinol Invest. https://doi.org/10.1007/s40618-020-01315-4
Cui L, He T, Jiang Y, Li M, Wang O, Jiajue R, Chi Y, Xu Q, Xing X, Xia W (2019) Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data. Osteoporos Int 31:307–316. https://doi.org/10.1007/s00198-019-05173-6
Mohsin S, Kaimala S, Sunny JJ, Adeghate E, Brown EM (2019) Type 2 Diabetes mellitus increases the risk to hip fracture in postmenopausal osteoporosis by deteriorating the trabecular bone microarchitecture and bone mass. J Diabetes Res 2019:3876957–3876910. https://doi.org/10.1155/2019/3876957
van Varsseveld NC, Sohl E, Drent ML, Lips P (2015) Gender-specific associations of serum insulin-like growth factor-1 with bone health and fractures in older persons. J Clin Endocrinol Metab 100:4272–4281. https://doi.org/10.1210/jc.2015-2549
Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83:4257–4262. https://doi.org/10.1210/jcem.83.12.5308
Muñoz-Torres M, Mezquita-Raya P, Lopez-Rodriguez F, Torres-Vela E, de Dios LJ, Escobar-Jimenez F (2001) The contribution of IGF-I to skeletal integrity in postmenopausal women. Clin Endocrinol (Oxf) 55:759–766. https://doi.org/10.1046/j.1365-2265.2001.01390.x
Garnero P, Sornay-Rendu E, Delmas PD (2000) Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 355:898–899. https://doi.org/10.1016/s0140-6736(99)05463-x
Pye SR, Almusalam B, Boonen S, Vanderschueren D, Borghs H, Gielen E, Adams JE, Ward KA, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC, O'Neill TW, EMAS Study Group (2011) Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: results from the European Male Ageing Study. Calcif Tissue Int 88:503–510. https://doi.org/10.1007/s00223-011-9484-2
Ohlsson C, Mellström D, Carlzon D, Orwoll E, Ljunggren O, Karlsson MK, Vandenput L (2011) Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J Bone Miner Res 26:865–872. https://doi.org/10.1002/jbmr.281
Center JR, Nguyen TV, Sambrook PN, Eisman JA (1999) Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 84:3626–3635. https://doi.org/10.1210/jcem.84.10.6051
Yeap BB, Alfonso H, Chubb SAP, Center JR, Beilin J, Hankey GJ, Almeida OP, Golledge J, Norman PE, Flicker L (2020) U-shaped association of plasma testosterone, and no association of plasma estradiol, with incidence of fractures in men. J Clin Endocrinol Metab 105:dgaa115. https://doi.org/10.1210/clinem/dgaa115
ES LB, Nielson CM, Marshall LM, Lapidus JA, Barrett-Connor E, Ensrud KE, Hoffman AR, Laughlin G, Ohlsson C, Orwoll ES, Osteoporotic Fractures in Men Study Group (2009) The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab 94:3337–3346. https://doi.org/10.1210/jc.2009-0206
Hsu B, Cumming RG, Seibel MJ, Naganathan V, Blyth FM, Bleicher K, Dave A, Le Couteur DG, Waite LM, Handelsman DJ (2015) Reproductive hormones and longitudinal change in bone mineral density and incident fracture risk in older men: the Concord Health and Aging in Men Project. J Bone Miner Res 30:1701–1708. https://doi.org/10.1002/jbmr.2493
Acknowledgments
We thank all the staff who did work in the Department of Endocrinology and Metabolism, Peking University People’s Hospital.
Funding
This work was supported by the National Natural Science Foundation of China (No.81970708, No.81970698, and No.81900805), Beijing Natural Science Foundation (No.7202216), and Project (No. RDY2019-22) supported by Peking University People’s Hospital Scientific Research Development Funds.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
None
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lv, F., Cai, X., Zhang, R. et al. Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes. Osteoporos Int 32, 1165–1173 (2021). https://doi.org/10.1007/s00198-020-05790-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-020-05790-6